Figure 1From: Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report Pre-injection examination revealed symblepharon and corneal opacity in the inferior sector with superficial and deep corneal neovascularization (arrows). Back to article page